Chapter 222

David Miller, CEO of Strykeris Biopharma, was celebrating with his legal team in the top-floor office.

"Eighty million for a two-year window? Totally worth it!"

David raised his champagne flute. "That young heir at the Russell Group is about to learn that money can't solve everything."

The chief...

Login and Continue Reading